The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data.
 
William Y. Kim
No Relationships to Disclose
 
Tracy L. Rose
Research Funding - Bristol-Myers Squibb; GeneCentric; Merck; Roche/Genentech; X4 Pharma
 
Florian Roghmann
No Relationships to Disclose
 
Markus Eckstein
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; AstraZeneca
 
Jonas Jarczyk
No Relationships to Disclose
 
Friedemann Zengerling
Honoraria - Bayer Health; Bristol-Myers Squibb; Ipsen; Novartis; Roche; Sanofi/Aventis
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche; Sanofi/Aventis
Travel, Accommodations, Expenses - Bayer Health; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche
 
Danijel Sikic
No Relationships to Disclose
 
Johannes Breyer
No Relationships to Disclose
 
Christian Bolenz
Honoraria - AstraZeneca; AstraZeneca; Janssen-Cilag; Medac; Takeda
Research Funding - ERBE Elektromedizin (Inst)
 
Arndt Hartmann
Consulting or Advisory Role - Janssen Research & Development
Speakers' Bureau - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cepheid; Janssen; MSD; NanoString Technologies; Novartis; Roche
Research Funding - BioNTech; Cepheid; Janssen; Janssen Research & Development; Roche
 
Gregory Mayhew
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Research Funding - GeneCentric
Patents, Royalties, Other Intellectual Property - I hold no patents. But just in case want to say I've signed legal documents for the company I am employed by (GeneCentric Therapeutics) transferring patent rights associated with inventions I've worked on to the company.
Travel, Accommodations, Expenses - GeneCentric
 
Yoichiro Shibata
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Research Funding - GeneCentric
Patents, Royalties, Other Intellectual Property - Patent pending for Tumor Mutation Burden (TMB) from RNA-seq
 
Joshua M. Uronis
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Consulting or Advisory Role - Bristol-Myers Squibb (I)
Research Funding - Advaxis (I); Bristol-Myers Squibb (I); Macrogenics (I); Merck (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I)
 
Aaron Galluzzi
Employment - Janssen Research & Development
 
Ramesh Sundaram
Employment - Janssen Research & Development
 
Qi Xia
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Kathy Wu
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Ademi E. Santiago-Walker
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Philipp Erben
No Relationships to Disclose
 
Ralph Wirtz
Employment - STRATIFYER Molecular Pathology
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology
Patents, Royalties, Other Intellectual Property - STRATIFYER Molecular Pathology